Breast and Gynecological Cancer Benefit Finding Scale: Turkish Validity and Reliability Study

This study aimed to determine the validity and reliability of the "Benefit Finding Scale" (BFS) in Turkish breast and gynecologic cancer patients.

In the methodological research, 322 women were included. Data was collected using the "Descriptive Information Form" and the "BFS." The language, content, construct, criterion, and convergent validity of the "BFS" were examined. Content validity was assessed using the scale and the item content validity index. Construct validity was determined by Exploratory factor analysis and Confirmatory factor analysis. The reliability of the scale was evaluated using internal consistency analysis, Cronbach's α, and the test-retest method.

Exploratory and confirmatory factor analyses established that the scale consisted of 15 items with three factors, explaining 72.5% of the total variance. Confirmatory Factor Analysis Fit Indices Goodness of Fit Index: 0.96, AGFI: 0.95, NFI: 0.95, PGFI: 0.70, RMR: 0.08. The Cronbach's α for the total scale is 0.92. Within the scope of the test-retest analysis, an interclass correlation coefficient = 0.961 was determined. The scale evaluation is based on the mean scores of the subdimensions and total scores; as the score obtained from the scale increases, the benefit finding for cancer increases.

The findings from this study conducted on a sample of breast and gynecologic cancer showed that the "BFS" is both valid and reliable for the Turkish population.

Assessing benefit findings in women with breast and gynecologic cancer may enable nurses to provide care and psychosocial support tailored to patient's needs, which can enhance their well-being and improve treatment adherence.